Tech Company Financing Transactions

Aragon Pharmaceuticals Funding Round

Topspin Partners, Aisling Capital and OrbiMed joined a $42 million Series C capital raise for Aragon Pharmaceuticals. The round was announced by the company on 3/6/2012.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

12780 El Camino Real 301
San Diego, CA 92130
USA

Phone

(858) 369-7600

Website

www.aragonpharmaceuticals.com

Email Address

[email protected]

Overview

Aragon Pharmaceuticals is a San Diego based biopharmaceutical company focused on developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Financial Officer

Paul Cleveland

        

Chief Medical Officer

Isan Chen

        

President

Richard Heyman

        

VP - Bus. Development

Angie You

        

Browse more venture capital transactions:

Prev: 3/6/2012: Drillinginfo venture capital transaction
Next: 3/6/2012: Valerion Therapeutics venture capital transaction

Share this article

About Our VC Transactions Data

Our team works diligently to report on tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary